drugset / Trial / NCT01374217
Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the anti-tumor efficacy of tadalafil in combination with Lenalidomide/dexamethasone (Rd) in multiple myeloma.
Timeline
- Start
- 2012-04
- Primary completion
- 2014-01
- Completion
- 2014-01
Outcome
Outcome not reported
Stopped: “early stopping rule”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tadalafil | Small molecule | 20 mg | Oral |
| Background | Clarithromycin | Small molecule | — | — |
| Background | Dexamethasone | Small molecule | — | — |
| Background | Lenalidomide | Other / unclassified | — | — |